ACLARIS THERAPEUTICS INC

Inside look: ACLARIS CSO’s recent share buy and sale reveal confidence in its dermatology pipeline and a steady long‑term stake, boosting investor sentiment.

Insider buying surges at Aclaris Therapeutics—directors pile on shares ahead of a Phase III launch, signaling confidence and potential upside for investors.

Insider buying at Aclaris Therapeutics shows CEO Walker Neal’s confidence—an RSU grant signals long‑term commitment amid market volatility.

Loerop James’ recent bulk purchase of Aclaris Therapeutics shares signals insider confidence, but investors should weigh the company’s earnings challenges and upcoming milestones before acting.